Active aGeing And Personalised Service's Ecosystem (AGAPE) Aims to Implement an Advanced Technology Platform That Provides Services to the Elderly, Formal and Informal Caregivers, and Caregiving Organizations
NCT ID: NCT06859489
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
68 participants
INTERVENTIONAL
2024-02-06
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anticipating and Tracking: Pack of Gerontological Assessment Embedded
NCT02818439
INNOVATEDIGNITY: Co-designing Digital Health Technologies With Older People in Homecare Settings.
NCT04884711
City For All Ages: Elderly-friendly City Services for Active and Healthy Ageing
NCT06486935
Optimizing Prevention of Hospital-Acquired Disability Through Multidomain Interventions
NCT06611228
After Discharge Management of Low Income Frail Elderly
NCT00328848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
1. Primary end users (i.e., older adults);
2. Secondary end users, in the figure of informal caregivers (i.e., relatives and friends of the elderly);
3. Secondary end users, in the figure of formal caregivers (i.e., social and health workers with different professional trainings, such as nurses, home care workers, geriatricians etc...);
4. Tertiary end users (i.e., care organizations, local authorities, municipalities).
The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including:
1. promotion of a healthy and active lifestyle;
2. socialization services;
3. digital health literacy service.
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
primary end-users
The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including:
1. promotion of a healthy and active lifestyle;
2. socialization services;
3. digital health literacy service.
Active aGeing And Personalised service's Ecosystem (AGAPE)
The experimental protocol is structured into two phases:
Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into:
Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities.
Testing phase: Use of the platform in the home environment of older adults for one month.
Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.
formal caregiver
formal caregivers are social operators with different background. The service provides support to formal caregivers in defining and updating the patient's activity plan over time, ensuring it adapts to their needs.
Active aGeing And Personalised service's Ecosystem (AGAPE)
The experimental protocol is structured into two phases:
Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into:
Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities.
Testing phase: Use of the platform in the home environment of older adults for one month.
Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.
informal caregiver
Informal caregivers will be able to receive notifications of any anomalies on their devices and, if necessary, draw the attention of the formal caregiver.
Active aGeing And Personalised service's Ecosystem (AGAPE)
The experimental protocol is structured into two phases:
Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into:
Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities.
Testing phase: Use of the platform in the home environment of older adults for one month.
Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.
Tertiary end users
Tertiary end users (i.e., care organizations, local authorities, municipalities).
The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including:
1. promotion of a healthy and active lifestyle;
2. socialization services;
3. digital health literacy service.
Active aGeing And Personalised service's Ecosystem (AGAPE)
The experimental protocol is structured into two phases:
Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into:
Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities.
Testing phase: Use of the platform in the home environment of older adults for one month.
Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active aGeing And Personalised service's Ecosystem (AGAPE)
The experimental protocol is structured into two phases:
Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into:
Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities.
Testing phase: Use of the platform in the home environment of older adults for one month.
Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand the rationale and characteristics of the study and to provide informed consent
* Low level of frailty, indicated by a score \<5 on the Rockwood Clinical Frailty Scale (Rockwood et al., 2005)
* Absence of moderate to severe cognitive impairment, indicated by a Mini-Mental State Examination (MMSE) score ≥ 24 (adjusted score; Folstein, 1975)
* Absence of severe comorbidities and clinically relevant diseases
Exclusion Criteria
* Inability to provide informed consent for participation in the study
* High level of frailty (Rockwood Clinical Frailty Scale \> 5)
* Presence of cognitive impairment (adjusted MMSE score \< 24)
* Diagnosed anxiety and depression
* Presence of severe disability and serious health conditions
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MEDEA SRL
UNKNOWN
Carol Davila University of Medicine and Pharmacy
OTHER
Caritas Diocesana de Coimbra
UNKNOWN
Be-Com
UNKNOWN
SenLab d.o.o.
UNKNOWN
Umana Persone
UNKNOWN
Fondazione Don Carlo Gnocchi Onlus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Fondazione Don Carlo Gnocchi, Firenze
Florence, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGAPE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.